UNC93B2

Across TCGA pan-cancer cohorts, UNC93B2 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated UNC93B2 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher UNC93B2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated UNC93B2 expression acts as an unfavorable survival marker, although some lineages such as BLCA and READ show a favorable association.

BLCA, LGG, and READ are the cancer types where UNC93B2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.701	0.512	<.001	93	view →
LGG	DFS	Median	All	0.665	0.810	<.001	37	view →
READ	OS	Median	II,III,IV	0.783	0.560	.015	22	view →
HNSC	OS	Tertile	All	0.470	0.688	.009	22	view →
UVM	DFS	Tertile	II,III,IV	0.797	0.438	.006	16	view →
THCA	DFS	Tertile	All	0.899	0.788	.007	12	view →
ACC	OS	Median	All	0.710	0.874	.012	11	view →
COAD	DFS	Tertile	All	0.714	0.847	.011	10	view →
CESC	DFS	Quartile	IV	0.274	0.700	.027	6	view →
CHOL	DFS	Tertile	III,IV	0.133	0.779	.038	6	view →
LAML	DFS	Quartile	All	0.435	0.765	.013	6	view →
SARC	OS	Quartile	All	0.926	0.836	.006	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

UNC93B2–BLCA (OS)

Open the BLCA breakdown →